impact on the overuse decline. A before-and-after interrupted time series analysis showed that the overuse measures were on the downturn prior to the recommendations being published. Then after publication, only the rate of CXR use in asthma decreased immediately. The rate of bronchodilator use for bronchiolitis declined in the following five-year period. There were no changes in the rate of decline in overuse for the other tests and treatments associated with the recommendations.
With such a widespread national campaign, a control group of hospitals to better understand the specific influence of the Choosing Wisely ® recommendations was not possible. The decline in overuse over the 10-year period reported by Reyes et al. is likely due to a combination of efforts at multiple levelsincluding national society guidelines, local hospital guidelines and pathways, increased awareness by clinicians of the problem of overuse, and focused quality improvement efforts.
The use of the PHIS database provided Reyes et al. a powerful data source to evaluate overuse across a large number of patients and hospitals efficiently. However, there are limitations with administrative data that are important to consider. Detailed clinical data, such as patient disease characteristics and test and treatment indications, are not available, which limits the specificity of these measures. For example, one of the recommendations suggests that gastroesophageal reflux should not be routinely treated with acid suppression therapy. Using administrative data, it is impossible to know whether the use of antacids in hospitalized children with a primary discharge diagnosis code of gastroesophageal reflux was inappropriate or because they failed other treatments in the outpatient setting and/or had complicated disease appropriately warranting treatment. This misclassification would result in an overestimation of overuse. The authors did attempt to minimize the possibility of misclassification by excluding children with comorbidities, those who had longer hospital stays, those admitted to the intensive care unit, and those with greater severity of illness where some of these tests and treatments would be indicated.
While the report by Reyes et al. focuses on Pediatric Hospital Medicine Choosing Wisely ® recommendations, it is important to recognize that tests and treatments for conditions like asthma, bronchiolitis, and lower respiratory tract infections are initially performed in the emergency department (ED). Collaboration between the ED and the Hospital Medicine Unit is essential to tackle the issue of overuse. 4 The study by Reyes et al. provides a nice description of the trends in the Choosing Wisely ® overuse metrics at a group of children's hospitals and is one of few such reports. The NIH fund-ed, Eliminating Monitor Overuse: pulse oximetry (EMO: SpO2) study is focusing on the 5th Choosing Wisely ® Pediatric Hospital Medicine recommendation that was not studied by Reyes. 5 So then, with the decline in overuse reported in this study over 10 years, is it time to celebrate? Not yet. There is much work to do in the pursuit of Choosing Wisely ® : developing a host of valid measures of overuse in pediatric hospital care, expanding the examination of overuse to community hospitals where the majority of children are hospitalized, and using implementation science theory to de-implement the ingrained practices.
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